- Home
- Applications
- congo
- oncologist
Refine by
Oncologist Product Applications Available In Congo
25 applications found
For the world’s leading radiation oncologists, cancer treatment has changed dramatically in recent years. ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
It increases productivity and enhances collaboration among surgical and radiation oncologists. Breast cancer treatment with IORT is precise and flexible. ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
The reputation of your cancer treatment facility hinges on your ability to recruit world-class oncologists. Those who can collaborate to leverage pioneering technologies and therapies for the benefit of their patients. ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
However, with the influx of new treatments also comes an “information avalanche.” Simply put, oncologists are struggling with the sheer volume of information they need to keep track of in order to match each individual patient with the best treatment for their unique needs. ...
ByBrightInsight, Inc based in San Jose, CALIFORNIA (USA)
For surgical oncologists, Mobetron serves a critical collaborative role in efficiently and effectively delivering an ablative dose of radiation directly to the tumor bed at the optimal biological time. ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Prancer RTSM? enables you to follow the science. Whether you have a simple, first-in-human study or complex dose escalation trials, our RTSM solutions provide the flexibility to adapt and scale alongside your Phase 1 trials. ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
Simplifying The Complexities of Modern Health ...
ByNantHealth, Inc. based in Morrisville, NORTH CAROLINA (USA)
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Sinus, Nasal, Maxillo-Facial, Mandibular, Aural, Brain, Trauma, Oncology, Neuro Angiography with SeeFactor ...
ByEpica Human Health based in Duncan, SOUTH DAKOTA (USA)
Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...
ByinDNA Research Labs based in , INDIA
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
ByRareStone Group based in Shanghai, CHINA
The IntraOp® Mobetron® is the most comprehensive electron therapy linear accelerator system with applications in intraoperative radiotherapy (IORT) and non-invasive treatment of skin cancer. Now Mobetron is the first to offer ultra-high dose rate electron therapy for preclinical and investigational studies of FLASH radiotherapy on an established clinical radiotherapy platform. IntraOp’s advanced technology ushers in a new paradigm for cancer treatment by providing researchers an approach not possible ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
All your data in one place. Athelas delivers patient vitals into 80+ EHRs including Epic, Cerner and Athena. Seamlessly integrate RPM datapoints into your existing protocols for patient care and maximize clinical ...
ByAthelas Incorporated based in Mountain View, CALIFORNIA (USA)
You likely already know that electron-beam IORT has been successfully treating multiple cancer indications for nearly 50 years and has been treating breast cancer since the early 1990’s. The first accelerated partial breast irradiation (APBI) treatment with the IntraOp® Mobetron® was performed in 2006. Today, more than 20,000 women have been treated with electron IORT demonstrating equivalency in local control with reduced toxicity and improved cosmesis. More than 10,000 breast cancer patients have ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
Healthcare is the primary domain of application of our disinfection technology. In addition to environmental inanimate surfaces and fomites, our systems are particularly suited for the disinfection of non-invasive medical devices whose complex surfaces make their cleaning and pathogens’ eradication particularly challenging. All areas of hospitals and medical specialties can benefit for the use of 99T’s systems, from surgery rooms to transplants units, from patients rooms to surgical theaters, from ...
By99 Technologies S.A. based in Lugano, SWITZERLAND
Using our platform, we are developing mRNA medicines for diverse uses and delivering them to patients across the globe. We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and overtreatment of men with indolent disease.4 ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)
The global medical devices sector is undergoing a period of significant transformation largely driven by demographic shifts, evolving patient needs and technological advancements. An ageing population, combined with lifestyle related factors has resulted in a global increase in the prevalence of chronic diseases. As a result, early detection, prevention and improved management of chronic diseases has become an increasing focus for healthcare systems across the ...
ByMorgan Advanced Materials based in Windsor, NORTHERN IRELAND